# Vicore Pharma Holding AB (publ) (VCRE)

> Source: Nexqual · https://nexqual.com/VCRE · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Vicore Pharma Holding AB (publ) (VCRE), nexqual.com/VCRE" · informational, not investment advice.

**Price:** USD 9.09 (+0.11% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 9.08 · day 8.93–9.3 · 52w 7.88–17.8 · market cap $256M · NCM

## Key facts
- Analysts: Buy (mean 2.00 on a 1–5 scale) (2 analysts), mean target USD 29.25 (range 25.16–33.35).
- Total return with dividends: 1Y -44.1% vs S&P 500 +18.1%; 5Y -34.0% vs S&P 500 +85.1%.

## Analysts
Consensus Buy (mean 2.00 on a 1–5 scale), 2 analysts; mean target USD 29.25 (low 25.16, high 33.35).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-09 | Jefferies | Initiated | Buy | $25 |

## Total return (dividends reinvested)
|  | 1Y (from 2026-07-06) | 5Y (from 2026-07-06) |
|---|---|---|
| Total return | -44.1% | -34.0% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | — | — |
| Volatility (annualized) | 47.4% | 42.6% |
| Max drawdown | -46.7% (Jul 2026→Oct 2026) | -34.7% (Jul 2026→Oct 2026) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/VCRE · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt